Evidence map›Paper›PMID 25078134›Full record

ArticleFuture medicinal chemistry2014

Synthesis of medicinally relevant terpenes: reducing the cost and time of drug discovery.

Daniel J Jansen, Ryan A Shenvi

Abstract read
In one paragraph

Article in Future medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Stereodivergent Construction ofJournal of the American Chemical Society · 2026
    Article
  2. Article
  3. Review
  4. Via Air or Rhizosphere: The Phytotoxicity ofPlants (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Total syntheses of strained polycyclic terpenes.Chemical communications (Cambridge, England) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. A Study of an 8-Aminoquinoline-Directed C(spThe Journal of organic chemistry · 2021
    Article
  15. Anti-protozoal activity of Thymol and a Thymol ester against Cryptosporidium parvum in cell culture.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Secondary Metabolites from Gorgonian Corals of the GenusMolecules (Basel, Switzerland) · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel J JansenDepartment of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Ryan A Shenvi

Funding

New Methods and Strategies for the Synthesis of Anticancer AlkaloidsR01GM104180 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SHENVI, RYAN ASHOK · 2013 to 2016
$1.4M
NIGMS NIH HHS GM104180NIGMS NIH HHS R01 GM104180
6 · The paper itself

Abstract

Terpenoids constitute a significant fraction of molecules produced by living organisms that have found use in medicine and other industries. Problems associated with their procurement and adaptation for human use can be solved using chemical synthesis, which is an increasingly economical option in the modern era of chemistry. This article documents, by way of individual case studies, strategies for reducing the time and cost of terpene synthesis for drug discovery. A major trend evident in recent syntheses is that complex terpenes are increasingly realistic starting points for both medicinal chemistry campaigns and large-scale syntheses, at least in the context of the academic laboratory, and this trend will likely penetrate the commercial sector in the near future.

Indexed as

Chemistry Techniques, SyntheticDrug DiscoveryHumansPharmaceutical PreparationsTerpenesTime FactorsPharmaceutical PreparationsTerpenes

Identifiers

PMID25078134
PMCPMC4162426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.